Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Film-coated tablet: 30 mg, 60 mg
Registered products in the Philippines
5 products registered with the Food and Drug Administration (FDA) Philippines list Daclatasvir as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products5
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
Dacihep 60Daclatasvir (as dihydrochloride) | 60 mg Film Coated TabletHDPE plastic bottle x 28’s (Box of 28’s) | Rx | Cadila Healthcare LimitedIndia | Zydus Healthcare Philippines, Inc.Trader: N/A | DR-XY48174 | Jul 6, 2027 | |
Mydekla 60Daclatasvir (as hydrochloride) | 60 mg Film Coated TabletHDPE Bottle x 28's (Box of 1's x 28 tablets) | Rx | Mylan Laboratories LimitedIndia | Viatris Pharmaceuticals, Inc. | DR-XY46053 | Oct 3, 2027 | |
Mydekla 60Daclatasvir (as hydrochloride) | 60 mg Film Coated TabletHDPE Bottle x 28's (Box of 1's x 28 tablets) | Rx | Mylan Laboratories LimitedIndia | Viatris Pharmaceuticals, Inc. | DRP-16184 | Oct 3, 2027 | |
Virdac 30Daclatasvir (as dihydrochloride) | 30 mg Film-Coated TabletWhite opaque HDPE bottle with white opaque child resistant PP cap containing 28 tablets (Box of 28 tablets) | Rx | Hetero Labs Limited (Unit V)India | Camber Pharmaceuticals, Inc. | DR-XY47942 | Apr 18, 2027 | |
Virdac 60Daclatasvir (as dihydrochloride) | 60 mg Film-Coated TabletWhite opaque HDPE bottle with white opaque child - resistant PP cap containing 28 tablets (Box of 28 tablets) | Rx | Hetero Labs Limited (Unit V)India | Camber Pharmaceuticals, Inc. | DR-XY47943 | Apr 18, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Government price references
| Preparation | Price (PHP) | Unit | Type |
|---|---|---|---|
| Daclatasvir 60 mg tablet | ₱114.29 | per tablet | DPRI reference price |
Reference price based on the DOH Central Office Bids and Awards Committee procurement price 2020
These are government procurement and reimbursement references, not retail prices. Sources:
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf, as of September 17, 2021
Formulary and coverage
| Philippine National Formulary | Listed as Daclatasvir |
| PNF listing | Oral: 60 mg tablet |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
- DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .